Nuvectis Pharma, Inc. (NASDAQ:NVCT) Sees Large Decline in Short Interest
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 1,340,000 shares, a decrease of 14.1% from the February 13th total of 1,560,000 shares. Currently, 11.1% of the shares of the stock are sold short. Based […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 1,340,000 shares, a decrease of 14.1% from the February 13th total of 1,560,000 shares. Currently, 11.1% of the shares of the stock are sold short. Based […]